Peak Bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
Peak Bio, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $0 as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2024-11-12
- 2024-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $0.00.
- 2024-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $0.00.
- 2024-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $0.00.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $0.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-23 |
| 2024-03-31 | $0.00 10-Q · filed 2024-08-23 |
| 2023-12-31 | $0.00 10-K · filed 2024-08-06 |
| 2023-09-30 | $0.00 10-Q · filed 2024-06-25 |
| 2023-06-30 | $107.41K 10-Q · filed 2023-08-18 |
| 2023-03-31 | $47.33K 10-Q · filed 2023-07-12 |
| 2022-12-31 | $486.10K 10-K · filed 2023-06-29 |